Nov 28, 2025 05:28
PFE - Pfizer Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 24.5 0.57 (2.31%) | -0.01 (-0.04%) | 0.0 (0.0%) | -0.1 (-0.4%) | 0.12 (0.49%) | 0.48 (1.95%) | 0.02 (0.09%) | 0.28 (1.15%) |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- 0.51
- Diluted EPS:
- 0.51
- Basic P/E:
- 49.1471
- Diluted P/E:
- 49.1471
- RSI(14) 1m:
- 58.7
- VWAP:
- 25.07
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 28, 2025 03:50
Nov 27, 2025 15:00
Nov 27, 2025 12:54
Nov 27, 2025 09:01
Nov 26, 2025 09:15
Nov 25, 2025 11:24
Nov 25, 2025 10:30
Nov 24, 2025 12:00
Nov 22, 2025 14:20